Effects of Pharmacological Treatment on Telomere Length and the Expression of Telomerase/Shelterin-Related Genes in Rat Models of Autism

Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in b...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular neuroscience Vol. 75; no. 2; p. 55
Main Authors Valeeva, Elena V., Nikitin, Dmitry O., Nikiforova, Lubov S., Semina, Irina I., Ahmetov, Ildus I.
Format Journal Article
LanguageEnglish
Published New York Springer US 24.04.2025
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes ( Dkc1 , Gar1 , Pot1a , Pot1b , Tep1 , Terc , Terf2ip , Tert , Tinf2 , Tnks , Tpp1 , Trf1 , and Trf2 ) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1 , Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD.
AbstractList Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes (Dkc1, Gar1, Pot1a, Pot1b, Tep1, Terc, Terf2ip, Tert, Tinf2, Tnks, Tpp1, Trf1, and Trf2) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1, Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD.
Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes (Dkc1, Gar1, Pot1a, Pot1b, Tep1, Terc, Terf2ip, Tert, Tinf2, Tnks, Tpp1, Trf1, and Trf2) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1, Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD.
Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes (Dkc1, Gar1, Pot1a, Pot1b, Tep1, Terc, Terf2ip, Tert, Tinf2, Tnks, Tpp1, Trf1, and Trf2) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1, Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD.Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes (Dkc1, Gar1, Pot1a, Pot1b, Tep1, Terc, Terf2ip, Tert, Tinf2, Tnks, Tpp1, Trf1, and Trf2) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1, Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD.
Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes ( Dkc1 , Gar1 , Pot1a , Pot1b , Tep1 , Terc , Terf2ip , Tert , Tinf2 , Tnks , Tpp1 , Trf1 , and Trf2 ) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1 , Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD.
ArticleNumber 55
Author Nikitin, Dmitry O.
Ahmetov, Ildus I.
Valeeva, Elena V.
Semina, Irina I.
Nikiforova, Lubov S.
Author_xml – sequence: 1
  givenname: Elena V.
  surname: Valeeva
  fullname: Valeeva, Elena V.
  organization: Central Research Laboratory, Kazan State Medical University, Laboratory of Genetics of Aging and Longevity, Kazan State Medical University
– sequence: 2
  givenname: Dmitry O.
  surname: Nikitin
  fullname: Nikitin, Dmitry O.
  organization: Pharmacology Department, Kazan State Medical University
– sequence: 3
  givenname: Lubov S.
  surname: Nikiforova
  fullname: Nikiforova, Lubov S.
  organization: Central Research Laboratory, Kazan State Medical University
– sequence: 4
  givenname: Irina I.
  surname: Semina
  fullname: Semina, Irina I.
  organization: Central Research Laboratory, Kazan State Medical University, Pharmacology Department, Kazan State Medical University
– sequence: 5
  givenname: Ildus I.
  orcidid: 0000-0002-6335-4020
  surname: Ahmetov
  fullname: Ahmetov, Ildus I.
  email: i.akhmetov@ljmu.ac.uk
  organization: Central Research Laboratory, Kazan State Medical University, Laboratory of Genetics of Aging and Longevity, Kazan State Medical University, Research Institute for Sport and Exercise Sciences, Liverpool John Moores University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40272729$$D View this record in MEDLINE/PubMed
BookMark eNp9ks-OFCEQxolZ4_7RF_BgSLx4aZeC7hn6ZDabcTUZo1nHM6Hp6mk2NIxAG30DH1t2Z1xXD6ZCIOFXX1XBd0qOfPBIyHNgr4Gx5XkCzgRUjDdliUZU9SNyAk3TVgCLxdGD8zE5TemGMQ41yCfkuGZ8WaI9IT9Xw4AmJxoG-mnUcdImuLC1Rju6iajzhD7T4OkGXZgwIl2j3-aRat_TPCJdfd9FTMkWpEgcKJ3w_POILmO0vrpGpzP29Ao9Jmo9vdaZfgg9uruyF3O2aXpKHg_aJXx22M_Il7erzeW7av3x6v3lxboyNZe56pBxZEZDL5B1TOt6yUWnBZMG-4FjLRnKEih5L2XbNkZioY0E6DhvjDgjb_a6u7mbsDdlvKid2kU76fhDBW3V3zfejmobvqny2ByWQhSFVweFGL7OmLKabDLonPYY5qQEtDVfMAa36Mt_0JswR1_mU4KDaKBEU6gXD1u67-X3LxWA7wETQ0oRh3sEmLq1gtpbQRUrqDsrqLokiX1SKrDfYvxT-z9ZvwB5KbgQ
Cites_doi 10.15585/mmwr.ss7001a1
10.5498/wjp.v13.i6.262
10.1111/jnc.12255
10.3389/fnins.2021.641284
10.1007/s11055-023-01458-w
10.1016/j.vascn.2020.106676
10.1093/nar/30.10.e47
10.1016/j.schres.2015.04.025
10.1016/j.semcancer.2011.07.001
10.17116/jnevro201911911141
10.1016/j.cell.2006.04.044
10.1016/j.jpsychires.2017.01.002
10.1016/j.biopsych.2019.04.028
10.1016/S0892-0362(00)00028-3
10.1186/s13229-016-0073-0
10.1007/s12035-015-9296-5
10.1128/MCB.20.5.1659-1668.2000
10.1038/sj.onc.1207582
10.1001/jama.2022.23661
10.1093/jnci/dju408
10.5607/en.2017.26.5.252
10.1080/10408440590964217
10.1073/pnas.1607426113
10.1007/s12035-013-8535-2
10.1155/2019/5046867
10.1002/aur.2307
10.1038/s41588-022-01148-2
10.1007/s00109-002-0374-5
10.3390/ijms222111855
10.1158/1541-7786.mcr-05-0147
10.52600/2763-583X.bjcr.2023.3.1.16-23
10.1002/humu.21220
10.1002/hipo.23264
10.1016/j.jad.2015.11.052
10.1093/rheumatology/kez524
10.1073/pnas.2215632120
10.1016/j.arcmed.2022.09.006
10.1016/j.yfrne.2019.100818
10.1126/science.abn6840
10.1016/j.jaac.2013.11.014
10.1038/sj.npp.1300604
10.1016/j.pharmthera.2018.05.003
10.1186/2047-9158-2-17
10.1534/g3.112.004689
10.1111/j.1474-9726.2011.00741.x
10.1016/j.celrep.2014.10.022
10.1016/j.redox.2024.103278
10.1080/10715762.2021.2017913
10.1002/path.2500
10.1016/j.stemcr.2018.04.001
10.1182/blood-2014-04-568508
10.1016/j.neubiorev.2012.07.005
10.1016/j.schres.2008.04.003
10.3389/fpsyt.2023.1205199
10.1007/s10803-011-1215-z
10.1016/j.arr.2018.09.002
10.1007/s11033-010-0439-x
10.1016/j.tics.2012.09.006
10.1038/nrm2845
10.1038/srep07073
10.1038/nprot.2007.44
10.3389/fpsyt.2023.1209638
10.3791/50978
10.1038/tp.2015.125
10.1093/nar/gkg224
10.1016/j.neuropharm.2012.07.028
10.17750/KMJ2019-100-6-918
10.1006/meth.2001.1127
10.1016/j.csbj.2020.06.040
10.1016/j.mad.2022.111694
10.1038/sj.leu.2403086
10.1016/j.rasd.2022.102067
10.1016/j.exger.2013.12.004
10.1007/s10803-022-05486-2
10.1371/journal.pgen.1007782
10.1038/35011073
10.4103/1673-5374.324852
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
Copyright Springer Nature B.V. Jun 2025
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: Copyright Springer Nature B.V. Jun 2025
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QR
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
5PM
DOI 10.1007/s12031-025-02353-4
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Chemoreception Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE
Virology and AIDS Abstracts
MEDLINE - Academic
CrossRef


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1559-1166
ExternalDocumentID PMC12021733
40272729
10_1007_s12031_025_02353_4
Genre Journal Article
GeographicLocations Russia
GeographicLocations_xml – name: Russia
GrantInformation_xml – fundername: Russian Science Foundation
  grantid: 23-25-00325; 23-25-00325; 23-25-00325; 23-25-00325
  funderid: http://dx.doi.org/10.13039/501100006769
– fundername: Russian Science Foundation
  grantid: 23-25-00325
GroupedDBID ---
.86
.VR
06C
06D
0R~
0VY
1N0
203
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5RE
5VS
67N
6NX
78A
7X7
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANZL
AAPKM
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYZH
ABAKF
ABBRH
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACCUX
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACSTC
ACZOJ
ADBBV
ADHHG
ADHIR
ADKNI
ADKPE
ADTPH
ADURQ
ADYFF
ADZKW
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFLOW
AFOHR
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHMBA
AHPBZ
AHSBF
AHWEU
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ATHPR
AXYYD
AYFIA
B-.
BA0
BENPR
BGNMA
BSONS
C6C
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
ESBYG
F5P
FERAY
FFXSO
FIGPU
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
HF~
HG6
HMJXF
HRMNR
IJ-
IKXTQ
ITM
IWAJR
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
LLZTM
M4Y
MA-
N9A
NF0
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
P19
P2P
PF0
PT4
PT5
QOK
QOR
QOS
R89
R9I
RNS
ROL
RPX
RSV
S16
S1Z
S27
S3A
S3B
SAP
SBL
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
TSG
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
ZMTXR
ZOVNA
~A9
~EX
AAYXX
CITATION
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QR
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
5PM
TUS
ID FETCH-LOGICAL-c428t-be02e0ca1d3e0b0aa4723ba308cedf2e480e8e8ee82d88995c8eca1c811b225c3
IEDL.DBID U2A
ISSN 1559-1166
0895-8696
IngestDate Thu Aug 21 18:26:48 EDT 2025
Fri Jul 11 18:30:40 EDT 2025
Sun Jul 27 04:10:36 EDT 2025
Mon Jul 21 06:03:33 EDT 2025
Thu Jul 03 08:15:08 EDT 2025
Wed Jul 02 02:43:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Nooclerin
Autism
Amitriptyline
Risperidone
Expression genes
Telomere
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c428t-be02e0ca1d3e0b0aa4723ba308cedf2e480e8e8ee82d88995c8eca1c811b225c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6335-4020
OpenAccessLink https://link.springer.com/10.1007/s12031-025-02353-4
PMID 40272729
PQID 3213515155
PQPubID 326248
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12021733
proquest_miscellaneous_3194260013
proquest_journals_3213515155
pubmed_primary_40272729
crossref_primary_10_1007_s12031_025_02353_4
springer_journals_10_1007_s12031_025_02353_4
PublicationCentury 2000
PublicationDate 2025-04-24
PublicationDateYYYYMMDD 2025-04-24
PublicationDate_xml – month: 04
  year: 2025
  text: 2025-04-24
  day: 24
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Totowa
PublicationSubtitle MN
PublicationTitle Journal of molecular neuroscience
PublicationTitleAbbrev J Mol Neurosci
PublicationTitleAlternate J Mol Neurosci
PublicationYear 2025
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References WQ Fang (2353_CR18) 2014; 9
DP Kennedy (2353_CR31) 2012; 16
J Hellings (2353_CR26) 2023; 13
D Hockemeyer (2353_CR28) 2006; 126
Z Zeng (2353_CR81) 2020; 59
P Sołek (2353_CR70) 2021; 22
M Cirnigliaro (2353_CR13) 2023; 120
F Mamdani (2353_CR46) 2015; 5
A Smogorzewska (2353_CR69) 2000; 20
L Mirabello (2353_CR48) 2010; 31
T Aramburu (2353_CR3) 2020; 18
RJ O’Sullivan (2353_CR52) 2010; 11
2353_CR49
2353_CR45
EH Blackburn (2353_CR8) 2005; 3
GB Polho (2353_CR57) 2015; 165
TW Frazier (2353_CR20) 2014; 53
NA Bondarenko (2353_CR9) 2017; 4
Y Panahi (2353_CR55) 2023; 53
SM Banker (2353_CR5) 2021; 31
KK Ridout (2353_CR60) 2016; 191
J Wiltse (2353_CR77) 2005; 35
T Hirota (2353_CR27) 2023; 329
Z Sekne (2353_CR63) 2022; 375
M Solomon (2353_CR71) 2012; 42
T Zhang (2353_CR82) 2023; 14
GE Hodes (2353_CR29) 2019; 86
JL Ingram (2353_CR30) 2000; 22
2353_CR53
AA Walf (2353_CR74) 2007; 2
2353_CR10
2353_CR54
WY Yu (2353_CR80) 2008; 33
II Semina (2353_CR64) 2019; 100
JK Kern (2353_CR32) 2013; 2
NF Mathon (2353_CR47) 2001; 1
JW Shay (2353_CR67) 2011; 21
2353_CR15
A Rynkiewicz (2353_CR61) 2016; 7
Zhou, X., Feliciano, P., Shu, C., Wang, T., Astrovskaya, I., Hall, J. B., Obiajulu, J. U., Wright, J. R., Murali, S. C., Xu, S. X., Brueggeman, L., Thomas, T. R., Marchenko, O., Fleisch, C., Barns, S. D., Snyder, L. G., Han, B., Chang, T. S., Turner, T. N., Harvey, W. T., Nishida, A., O'Roak, B. J., Geschwind, D. H., SPARK Consortium, Michaelson, J. J., Volfovsky, N., Eichler, E. E., Shen, Y., & Chung, W. K (2353_CR83) 2022; 54
T Schneider (2353_CR62) 2005; 30
S Gao (2353_CR21) 2024; 75
JM Hansen (2353_CR25) 2021; 55
KC Kim (2353_CR36) 2013; 124
H Cherif (2353_CR12) 2003; 31
K Bisht (2353_CR7) 2016; 113
CR Lewis (2353_CR40) 2020; 13
W Klapper (2353_CR38) 2003; 17
N Monroy-Jaramillo (2353_CR50) 2017; 90
RM Cawthon (2353_CR11) 2002; 30
KJ Livak (2353_CR44) 2001; 25
B Porton (2353_CR58) 2008; 106
CA Finney (2353_CR19) 2020; 56
II Semina (2353_CR65) 2023; 53
H Liu (2353_CR43) 2021; 15
SR Sharma (2353_CR66) 2018; 190
X Xu (2353_CR79) 2019; 2019
KC Kim (2353_CR33) 2017; 26
Q Wang (2353_CR76) 2018; 48
G De Boeck (2353_CR16) 2009; 217
X Lin (2353_CR42) 2022; 99
M Angoa-Pérez (2353_CR1) 2013; 24
Z Li (2353_CR41) 2014; 4
PV Dixit (2353_CR17) 2020; 102
KC Kim (2353_CR34) 2016; 53
2353_CR73
PM Lansdorp (2353_CR39) 2022; 53
2353_CR72
A Wojtyla (2353_CR78) 2011; 38
HS Go (2353_CR23) 2012; 63
LG Aoude (2353_CR2) 2015; 107
S Coghlan (2353_CR14) 2012; 36
AK Mukherjee (2353_CR51) 2018; 14
Y Guo (2353_CR24) 2014; 124
2353_CR37
ELB Barrett (2353_CR6) 2011; 10
Gardner, M., Bann, D., Wiley, L., Cooper, R., Hardy, R., Nitsch, D., Martin-Ruiz, C., Shiels, P., Sayer, A.A., Barbieri, M., Bekaert, S., Bischoff, C., Brooks-Wilson, A., Chen, W., Cooper, C., Christensen, K., Meyer, T.D., Deary, I., Der, G., Roux, A. D., Fitzpatrick, A., Hajat, A., Halaschek-Wiener, J., Harris, S., Hunt, C., Jagger, C., Jeon, H.-S., Kaplan, R., Kimura, M., Lansdorp, P., Li, C., Maeda, T., Mangino, M., Nawrot, T.S., Nilsson, P., Nordfjall, K., Paolisso, G., Ren, F., Riabowol, K., Robertson, T., Roos, G., Staessen, J. A., Spector, T., Tang, N., Unryn, B., Harst, P., Woo, J., Xing, C., Yadegarfar, M. E., Park J. Y., Young, N., Kuh, D., von Zglinicki T., Ben-Shlomo Y., Halcyon Study Team (2353_CR22) 2014; 51
L Wang (2353_CR75) 2015; 8
EM Shipilova (2353_CR68) 2019; 119
A Aviv (2353_CR4) 2002; 80
KC Kim (2353_CR35) 2014; 49
GB Polho (2353_CR56) 2022; 17
A Prasad (2353_CR59) 2012; 2
References_xml – ident: 2353_CR45
  doi: 10.15585/mmwr.ss7001a1
– volume: 13
  start-page: 262
  issue: 6
  year: 2023
  ident: 2353_CR26
  publication-title: World Journal of Psychiatry
  doi: 10.5498/wjp.v13.i6.262
– volume: 124
  start-page: 832
  issue: 6
  year: 2013
  ident: 2353_CR36
  publication-title: J Neurochem
  doi: 10.1111/jnc.12255
– volume: 15
  year: 2021
  ident: 2353_CR43
  publication-title: Front Neurosci
  doi: 10.3389/fnins.2021.641284
– volume: 53
  start-page: 597
  issue: 4
  year: 2023
  ident: 2353_CR65
  publication-title: Neurosci Behav Physiol
  doi: 10.1007/s11055-023-01458-w
– ident: 2353_CR73
– volume: 102
  year: 2020
  ident: 2353_CR17
  publication-title: J Pharmacol Toxicol Methods
  doi: 10.1016/j.vascn.2020.106676
– volume: 30
  start-page: e47
  issue: 10
  year: 2002
  ident: 2353_CR11
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/30.10.e47
– volume: 165
  start-page: 195
  issue: 2–3
  year: 2015
  ident: 2353_CR57
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2015.04.025
– ident: 2353_CR54
– volume: 21
  start-page: 349
  year: 2011
  ident: 2353_CR67
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2011.07.001
– volume: 119
  start-page: 41
  issue: 11
  year: 2019
  ident: 2353_CR68
  publication-title: Zhurnal Nevrologii i Psikhiatrii Imeni S.S Korsakova
  doi: 10.17116/jnevro201911911141
– volume: 126
  start-page: 63
  issue: 1
  year: 2006
  ident: 2353_CR28
  publication-title: Cell
  doi: 10.1016/j.cell.2006.04.044
– volume: 90
  start-page: 26
  year: 2017
  ident: 2353_CR50
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2017.01.002
– volume: 86
  start-page: 421
  issue: 6
  year: 2019
  ident: 2353_CR29
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2019.04.028
– volume: 22
  start-page: 319
  issue: 3
  year: 2000
  ident: 2353_CR30
  publication-title: Neurotoxicol Teratol
  doi: 10.1016/S0892-0362(00)00028-3
– volume: 7
  start-page: 1
  year: 2016
  ident: 2353_CR61
  publication-title: Molecular Autism
  doi: 10.1186/s13229-016-0073-0
– volume: 53
  start-page: 40
  year: 2016
  ident: 2353_CR34
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-015-9296-5
– volume: 20
  start-page: 1659
  issue: 5
  year: 2000
  ident: 2353_CR69
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.20.5.1659-1668.2000
– ident: 2353_CR37
  doi: 10.1038/sj.onc.1207582
– volume: 329
  start-page: 157
  issue: 2
  year: 2023
  ident: 2353_CR27
  publication-title: JAMA
  doi: 10.1001/jama.2022.23661
– volume: 107
  start-page: dju408
  issue: 2
  year: 2015
  ident: 2353_CR2
  publication-title: Journal of the National Cancer Institute
  doi: 10.1093/jnci/dju408
– volume: 26
  start-page: 252
  issue: 5
  year: 2017
  ident: 2353_CR33
  publication-title: Experimental Neurobiology
  doi: 10.5607/en.2017.26.5.252
– volume: 8
  start-page: 578
  issue: 1
  year: 2015
  ident: 2353_CR75
  publication-title: Int J Clin Exp Pathol
– volume: 35
  start-page: 727
  issue: 8–9
  year: 2005
  ident: 2353_CR77
  publication-title: Crit Rev Toxicol
  doi: 10.1080/10408440590964217
– volume: 113
  start-page: 13021
  issue: 46
  year: 2016
  ident: 2353_CR7
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.1607426113
– volume: 49
  start-page: 512
  issue: 1
  year: 2014
  ident: 2353_CR35
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-013-8535-2
– volume: 2019
  start-page: 5046867
  year: 2019
  ident: 2353_CR79
  publication-title: Biomed Res Int
  doi: 10.1155/2019/5046867
– volume: 13
  start-page: 1094
  issue: 7
  year: 2020
  ident: 2353_CR40
  publication-title: Autism Res
  doi: 10.1002/aur.2307
– volume: 54
  start-page: 1305
  issue: 9
  year: 2022
  ident: 2353_CR83
  publication-title: Nat Genet
  doi: 10.1038/s41588-022-01148-2
– volume: 80
  start-page: 689
  year: 2002
  ident: 2353_CR4
  publication-title: J Mol Med
  doi: 10.1007/s00109-002-0374-5
– volume: 4
  start-page: 45
  issue: 4
  year: 2017
  ident: 2353_CR9
  publication-title: Cognitive Science in Moscow
– volume: 22
  start-page: 11855
  issue: 21
  year: 2021
  ident: 2353_CR70
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms222111855
– volume: 3
  start-page: 477
  issue: 4
  year: 2005
  ident: 2353_CR8
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.mcr-05-0147
– ident: 2353_CR15
  doi: 10.52600/2763-583X.bjcr.2023.3.1.16-23
– volume: 31
  start-page: 1050
  issue: 9
  year: 2010
  ident: 2353_CR48
  publication-title: Hum Mutat
  doi: 10.1002/humu.21220
– volume: 31
  start-page: 79
  issue: 1
  year: 2021
  ident: 2353_CR5
  publication-title: Hippocampus
  doi: 10.1002/hipo.23264
– volume: 191
  start-page: 237
  year: 2016
  ident: 2353_CR60
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2015.11.052
– volume: 59
  start-page: 940
  issue: 5
  year: 2020
  ident: 2353_CR81
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kez524
– volume: 120
  issue: 31
  year: 2023
  ident: 2353_CR13
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.2215632120
– volume: 53
  start-page: 741
  issue: 8
  year: 2022
  ident: 2353_CR39
  publication-title: Arch Med Res
  doi: 10.1016/j.arcmed.2022.09.006
– volume: 56
  year: 2020
  ident: 2353_CR19
  publication-title: Front Neuroendocrinol
  doi: 10.1016/j.yfrne.2019.100818
– volume: 375
  start-page: 1173
  issue: 6585
  year: 2022
  ident: 2353_CR63
  publication-title: Science
  doi: 10.1126/science.abn6840
– volume: 53
  start-page: 329
  issue: 3
  year: 2014
  ident: 2353_CR20
  publication-title: J Am Acad Child Adolesc Psychiatry
  doi: 10.1016/j.jaac.2013.11.014
– volume: 30
  start-page: 80
  issue: 1
  year: 2005
  ident: 2353_CR62
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300604
– volume: 190
  start-page: 91
  year: 2018
  ident: 2353_CR66
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2018.05.003
– volume: 2
  start-page: 1
  issue: 1
  year: 2013
  ident: 2353_CR32
  publication-title: Translational Neurodegeneration
  doi: 10.1186/2047-9158-2-17
– volume: 2
  start-page: 1665
  issue: 12
  year: 2012
  ident: 2353_CR59
  publication-title: G3: Genes, Genomes, Genetics
  doi: 10.1534/g3.112.004689
– volume: 10
  start-page: 913
  issue: 6
  year: 2011
  ident: 2353_CR6
  publication-title: Aging Cell
  doi: 10.1111/j.1474-9726.2011.00741.x
– volume: 9
  start-page: 1635
  issue: 5
  year: 2014
  ident: 2353_CR18
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.10.022
– volume: 33
  start-page: 244
  year: 2008
  ident: 2353_CR80
  publication-title: J Psychiatry Neurosci
– volume: 75
  year: 2024
  ident: 2353_CR21
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2024.103278
– volume: 55
  start-page: 1130
  issue: 11–12
  year: 2021
  ident: 2353_CR25
  publication-title: Free Radical Res
  doi: 10.1080/10715762.2021.2017913
– volume: 217
  start-page: 327
  issue: 3
  year: 2009
  ident: 2353_CR16
  publication-title: J Pathol
  doi: 10.1002/path.2500
– ident: 2353_CR53
  doi: 10.1016/j.stemcr.2018.04.001
– volume: 124
  start-page: 2767
  issue: 18
  year: 2014
  ident: 2353_CR24
  publication-title: Blood
  doi: 10.1182/blood-2014-04-568508
– volume: 36
  start-page: 2044
  issue: 9
  year: 2012
  ident: 2353_CR14
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2012.07.005
– volume: 106
  start-page: 242
  issue: 2–3
  year: 2008
  ident: 2353_CR58
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2008.04.003
– ident: 2353_CR49
  doi: 10.3389/fpsyt.2023.1205199
– volume: 42
  start-page: 48
  year: 2012
  ident: 2353_CR71
  publication-title: J Autism Dev Disord
  doi: 10.1007/s10803-011-1215-z
– volume: 48
  start-page: 11
  year: 2018
  ident: 2353_CR76
  publication-title: Ageing Res Rev
  doi: 10.1016/j.arr.2018.09.002
– volume: 38
  start-page: 3339
  year: 2011
  ident: 2353_CR78
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-010-0439-x
– volume: 16
  start-page: 559
  issue: 11
  year: 2012
  ident: 2353_CR31
  publication-title: Trends Cogn Sci
  doi: 10.1016/j.tics.2012.09.006
– volume: 11
  start-page: 171
  issue: 3
  year: 2010
  ident: 2353_CR52
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2845
– volume: 4
  start-page: 7073
  year: 2014
  ident: 2353_CR41
  publication-title: Sci Rep
  doi: 10.1038/srep07073
– volume: 2
  start-page: 322
  issue: 2
  year: 2007
  ident: 2353_CR74
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2007.44
– volume: 14
  start-page: 1209638
  year: 2023
  ident: 2353_CR82
  publication-title: Front Psych
  doi: 10.3389/fpsyt.2023.1209638
– volume: 24
  start-page: 50978
  issue: 82
  year: 2013
  ident: 2353_CR1
  publication-title: J vis Exp
  doi: 10.3791/50978
– volume: 5
  start-page: e636
  issue: 9
  year: 2015
  ident: 2353_CR46
  publication-title: Translational psychiatry
  doi: 10.1038/tp.2015.125
– volume: 31
  start-page: 1576
  issue: 5
  year: 2003
  ident: 2353_CR12
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkg224
– volume: 63
  start-page: 1028
  issue: 6
  year: 2012
  ident: 2353_CR23
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2012.07.028
– ident: 2353_CR72
– volume: 100
  start-page: 918
  issue: 6
  year: 2019
  ident: 2353_CR64
  publication-title: Kazan medical journal
  doi: 10.17750/KMJ2019-100-6-918
– volume: 25
  start-page: 402
  issue: 4
  year: 2001
  ident: 2353_CR44
  publication-title: Methods
  doi: 10.1006/meth.2001.1127
– volume: 18
  start-page: 1939
  year: 2020
  ident: 2353_CR3
  publication-title: Comput Struct Biotechnol J
  doi: 10.1016/j.csbj.2020.06.040
– ident: 2353_CR10
  doi: 10.1016/j.mad.2022.111694
– volume: 17
  start-page: 2007
  issue: 10
  year: 2003
  ident: 2353_CR38
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2403086
– volume: 99
  year: 2022
  ident: 2353_CR42
  publication-title: Research in Autism Spectrum Disorders
  doi: 10.1016/j.rasd.2022.102067
– volume: 51
  start-page: 15
  year: 2014
  ident: 2353_CR22
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2013.12.004
– volume: 53
  start-page: 2050
  issue: 5
  year: 2023
  ident: 2353_CR55
  publication-title: J Autism Dev Disord
  doi: 10.1007/s10803-022-05486-2
– volume: 14
  issue: 11
  year: 2018
  ident: 2353_CR51
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1007782
– volume: 1
  start-page: 203
  year: 2001
  ident: 2353_CR47
  publication-title: Nat Rev Cancer
  doi: 10.1038/35011073
– volume: 17
  start-page: 1156
  issue: 5
  year: 2022
  ident: 2353_CR56
  publication-title: Neural Regen Res
  doi: 10.4103/1673-5374.324852
SSID ssj0021418
Score 2.418945
Snippet Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 55
SubjectTerms Amitriptyline
Animal models
Animals
Antipsychotic Agents - pharmacology
Antipsychotic Agents - therapeutic use
Autism
Biomedical and Life Sciences
Biomedicine
Blood
Blood cells
Cell Biology
Drug therapy
Female
Gene expression
Genes
Hippocampus - drug effects
Hippocampus - metabolism
Male
Males
Neurochemistry
Neurology
Neurosciences
Prefrontal cortex
Prefrontal Cortex - drug effects
Prefrontal Cortex - metabolism
Proteomics
Rats
Rats, Wistar
Risperidone
Risperidone - pharmacology
Risperidone - therapeutic use
Shelterin Complex
Telomerase
Telomerase - genetics
Telomerase - metabolism
Telomere - drug effects
Telomere - metabolism
Telomere Homeostasis - drug effects
Telomere-binding protein
Telomere-Binding Proteins - genetics
Telomere-Binding Proteins - metabolism
Telomeres
TRF2 protein
Valproic acid
Valproic Acid - toxicity
Title Effects of Pharmacological Treatment on Telomere Length and the Expression of Telomerase/Shelterin-Related Genes in Rat Models of Autism
URI https://link.springer.com/article/10.1007/s12031-025-02353-4
https://www.ncbi.nlm.nih.gov/pubmed/40272729
https://www.proquest.com/docview/3213515155
https://www.proquest.com/docview/3194260013
https://pubmed.ncbi.nlm.nih.gov/PMC12021733
Volume 75
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwELVoe-GCoOUj0K6MhLiARWI7u84xWm2pAHGAXamcIjuesCt1napJJfoP-rMZe5OsltJDlVsysR29sT2TGb8h5B2iWlaq9FnimjNZJYKpDDjj2lgjJddjHbJ8v4_PFvLLeXreHQpr-mz3PiQZVurtYTeOCsh8-VXP0SKY3CMHqffdUYsXPB_crEQmqjse8__3dregO3bl3fTIf2KkYes5fUqedDYjzTcgPyOPwB2So9yhv7y-oe9pyOIMv8ePyO2GjrihdYX3B1pqDwWd90nltHZ0Dhf1Gq6AfgP3u11S7SxFY5DO_nSpsc430UnhVvfp5xJ8ZH3lWEigA0s9ZXVDV47-0C31RdUuQrc56nKzfk4Wp7P59Ix11RZYiS5IywzEHOJSJ1ZAbGKt5YQLo0WsSrAVB6liUHiB4lahl5aWClC6VElicFEoxQuy72oHrwg1wLNK6LG1JpU2M2qiYm4mcWJLRECnEfnQA1Bcbkg1ii19soerQLiKAFchI3LcY1R0E6wpBPelBX19moi8HR7j1PDxDu2gvkaZJAv8-4mIyMsNpEN36Db7EHQWEbUD9iDgabd3n7jVMtBv4wDRjxPY6MdeL7bjuv8zXj9M_A15zIPOSsblMdlvr67hBO2f1ozIQf7519fZiOxNx9NRUP6_0tsDNQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagHOBSAeURKGAkxAWsxo_ddY6rVasFlh5gK_UW-TFhV-o6VZNK9B_0ZzP2ZlNtCweUWzyxHX3jeCYz_oaQD4iqq7SLWeJGMFVxyXQBggljvVVKmKFJWb7Hw-mJ-no6OO1ocuJZmFvx-4OGC1Q7FouuRmYWydR98kChpxzT9ybDSe9cccV1dyjm789tbzx3rMm7SZG3IqNpwzl6THY7S5GO19A-IfcgPCV744Be8uqKfqQpdzP9FN8j12sS4obWFd7vyagjAHS-SSWndaBzOKtXcAF0BuFXu6AmeIomID383SXEhthFJ4Ub3MHPBcR4-jKwlDYHnkai6oYuA_1hWhpLqZ2lYceowc3qGTk5OpxPpqyrscAcOh4ts5ALyJ3hXkJuc2PUSEhrZK4d-EqA0jlovEALr9E3GzgNKO005xY_BU4-JzuhDvCSUAuiqKQZem8HyhdWj3Qu7Cjn3iECZpCRTxsAyvM1lUZ5Q5oc4SoRrjLBVaqM7G8wKrtl1ZRSxIKCsSpNRt73zbggYpTDBKgvUYYXiXWfy4y8WEPaD4fOcgw8FxnRW2D3ApFse7slLBeJdBsniN6bxE4_b_TiZl7_fo1X_yf-jjyczr_PytmX42-vySOR9FcxofbJTntxCW_QAmrt26T6fwBc3_-H
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgSIiXCRgfGQOMhHgBq_FHW-exKqsGTBOCTtpbZMcXWml1pjWT4D_Yn72z81HK4AHlLb7Yjn7n2Je7-x0hbxHVotRFiBI3gqmSS6YzEEwY66xSwoxMjPI9GR2dqs9nw7PfsvhjtHvnkmxyGgJLk68HF64cbBLfBCojC6VYA1-LZOouuYeWSnTUTkfT3uTiius2Vebvz21vR7fOmLdDJf_wl8ZtaPaQ7LbnRzppAH9E7oB_TPYmHm3n1S_6jsaIzvirfI9cN9TEa1qVeL-nqA6w0HkXYE4rT-dwXq3gEugx-B_1ghrvKB4M6eHPNkzWhy5aKdz2Bt8XELzsS89iMB04Guir13Tp6TdT01Bg7TwOO0G9Xq-ekNPZ4Xx6xNrKC6xAc6RmFlIBaWG4k5Da1Bg1FtIameoCXClA6RQ0XqCF02ixDQsNKF1ozi1-IAr5lOz4ysNzQi2IrJRm5JwdKpdZPdapsOOUuwIRMMOEvO8AyC8ago18Q6Uc4MoRrjzClauEHHQY5e1iW-dShDKDoVZNQt70zbhMgu_DeKiuUIZnkYufy4Q8ayDth0MTOrijs4ToLbB7gUDBvd3il4tIxY0TRJtOYqcfOr3YzOvfr7H_f-Kvyf2vH2f58aeTLy_IAxHVVzGhDshOfXkFL_FYVNtXUfNvAGbMB90
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Pharmacological+Treatment+on+Telomere+Length+and+the+Expression+of+Telomerase%2FShelterin-Related+Genes+in+Rat+Models+of+Autism&rft.jtitle=Journal+of+molecular+neuroscience&rft.au=Valeeva%2C+Elena+V&rft.au=Nikitin%2C+Dmitry+O&rft.au=Nikiforova%2C+Lubov+S&rft.au=Semina%2C+Irina+I&rft.date=2025-04-24&rft.pub=Springer+Nature+B.V&rft.issn=0895-8696&rft.eissn=1559-1166&rft.volume=75&rft.issue=2&rft.spage=55&rft_id=info:doi/10.1007%2Fs12031-025-02353-4&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1559-1166&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1559-1166&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1559-1166&client=summon